Vital Living earnings
This article was originally published in The Tan Sheet
Executive Summary
Phoenix-based nutritionals firm recorded a 2,513% increase in sales from continuing operations to $1 mil. with a net loss before discontinued operations of $2.79 mil. in the firm's third quarter (ended Sept. 30), compared with an $11.4 mil. loss the previous year, Vital Living says Nov. 22. The improvement was primarily due to the divestiture of Christopher's Original Formulas herbal supplement business and nutraceuticals firm MAF Bionutritionals; the sales reflect the firm's decision to focus solely on developing and marketing proprietary products, according to CEO Stuart Benson. Vital Living announced the rollout of X-Fat, a diet solution containing a patented form of liquid chitosan, to GNC stores nationwide Nov. 2. The company hopes the product will drive sales over the holiday season...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.